Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches. [PDF]
Diabetes CareSnaith JR +4 more
europepmc +1 more source
IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes. [PDF]
Pharmacol ResElmendorf AJ +5 more
europepmc +1 more source
Pancreatic amylin dynamically reconfigures distributed brain networks governing appetite regulation in mice. [PDF]
Mol MetabGezginer I +5 more
europepmc +1 more source
The Obesity Drug Revolution: New Frontiers in Pharmacotherapy. [PDF]
CureusManoria PC.
europepmc +1 more source
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. [PDF]
Diabetes TherVolčanšek Š +4 more
europepmc +1 more source
Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]
Physiol BehavKern KA +5 more
europepmc +1 more source
Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare. [PDF]
World J CardiolBhat S +3 more
europepmc +1 more source
Better care for people with diabetes and endocrine diseases [PDF]
, 2015 Meng H Tan, Peter Arvan
core +1 more source
Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification. [PDF]
Int J Mol SciYelleswarapu NK, Sidiropoulos C.
europepmc +1 more source
Fatty acid regulation of feeding in <i>Caenorhabditis</i> elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system. [PDF]
Proc Natl Acad Sci U S AZhu F +13 more
europepmc +1 more source